Prevalence of oral anticoagulant use among people with and without Alzheimer’s disease

BACKGROUND: Although cardio- and cerebrovascular diseases are common among people with Alzheimer’s disease (AD), it is unknown how the prevalence of oral anticoagulant (OAC) use changes in relation to AD diagnosis. We investigated the prevalence of OAC use in relation to AD diagnosis in comparison t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali Babar, Barkat, Vu, Mai, Koponen, Marjaana, Taipale, Heidi, Tanskanen, Antti, Kettunen, Raimo, Tiihonen, Miia, Hartikainen, Sirpa, Tolppanen, Anna-Maija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148467/
https://www.ncbi.nlm.nih.gov/pubmed/35643439
http://dx.doi.org/10.1186/s12877-022-03144-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9148467/
https://www.ncbi.nlm.nih.gov/pubmed/35643439
http://dx.doi.org/10.1186/s12877-022-03144-x

Ejemplares similares